Research has identified effects on blood vessel formation, growth factor expression, nitric oxide production, and cellular signaling cascades
Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
The stated rationale behind the blend is that its components appear in overlapping literatures copper-peptide matrix signaling on one side, repair and angiogenesis peptides on the other
When combined, these medications address different aspects of metabolic dysfunction without interfering with each other's mechanisms
